P5383Risk for major adverse cardiovascular events estimated by the TIMI Risk Score for Secondary Prevention TRS2P in patients with coronary artery disease did not impact lipid lowering treatment in clinica. (28th August 2018) - Gitt, A K; Lautsch, D; Lautsch, D; Horack, M; Horack, M; Baxter, C A; Baxter, C A; De Ferrari, G; De Ferrari, G; Ferrieres, J; Ferrieres, J; ,